NCT05395052 2023-09-21FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated5 enrolled
NCT04065555 2022-07-29Intratumoral Microdosing of TAK-981 in Head and Neck CancerPresage BiosciencesPhase EARLY_PHASE1 Completed12 enrolled